Citation: | WANG Yan, YAN Wei. Prioritizing lung health: Achieving effective prevention and treatment of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2025, 23(2): 194-197. doi: 10.16766/j.cnki.issn.1674-4152.003865 |
[1] |
Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2022 report[EB/OL]. (2021-11-15)[2022-04-18].
|
[2] |
陈典, 隆寰宇, 李姝润, 等. 2024年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2024, 27(13): 1533-1543. doi: 10.12114/j.issn.1007-9572.2023.0867
CHEN D, LONG H Y, LI S R, et al. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report[J]. Chinese General Practice, 2024, 27(13): 1533-1543. doi: 10.12114/j.issn.1007-9572.2023.0867
|
[3] |
GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Respir Med, 2020, 8(6): 585-596. doi: 10.1016/S2213-2600(20)30105-3
|
[4] |
ADELOYE D, SONG P, ZHU Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis[J]. Lancet Respir Med, 2022, 10(5): 447-458. doi: 10.1016/S2213-2600(21)00511-7
|
[5] |
SAFIRI S, CARSON-CHAHHOUD K, NOORI M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019[J]. BMJ, 2022, 378: e069679. DOI: 10.1136/bmj-2021-069679.
|
[6] |
陈亚红. 2020年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版), 2019, 11(12): 32-50.
CHEN Y H. Interpretation of global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2019, 11(12): 32-50.
|
[7] |
李香荷, 罗青, 唐娜, 等. 1990—2019年中国慢性阻塞性肺疾病死亡负担及变化情况分析[J]. 中国循环杂志, 2023, 38(6): 681-686.
LI X H, LUO Q, TANG N, et al. Analysis of the Death Burden and Changes in Chronic Obstructive Pulmonary Disease in China from 1990 to 2019[J]. Chinese Journal of Circulation, 2023, 38(6): 681-686.
|
[8] |
项文勤, 俞浩, 苏健, 等. 2015年与2019年江苏省40岁及以上人群慢性阻塞性肺疾病负担及吸烟归因疾病负担研究[J]. 中国慢性病预防与控制, 2022, 30(2): 81-86, 91.
XIANG W Q, YU H, SU J, et al. Study on the Burden of Chronic Obstructive Pulmonary Disease and Smoking Attributed Disease Burden in People Aged 40 and Over in Jiangsu Province in 2015 and 2019[J]. China Chronic Disease Prevention and Control, 2022, 30(2): 81-86, 91.
|
[9] |
LI H, LIANG H, WEI L, et al. Health inequality in the global burden of chronic obstructive pulmonary disease: findings from the Global Burden of Disease Study 2019[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 1695-1702. doi: 10.2147/COPD.S369120
|
[10] |
BURGE P S, CALVERLEY P M, JONES P W, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial[J]. BMJ, 320(7245): 1297-303. DOI: 10.1136/bmj.320.7245.1297.
|
[11] |
STOLBRINK M, THOMSON H, HADFIELD R M, et al. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review[J]. Lancet Glob Health, 2022, 10(10): e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8
|
[12] |
陈康勰, 黄耀光, 李辉, 等. 常用血常规指标对慢性阻塞性肺疾病急性加重的诊断价值[J]. 中国全科医学, 2020, 23(13): 4.
CHEN K X, HUANG Y G, LI H, et al. The diagnostic value of commonly used blood routine indicators for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese General Practice, 2020, 23(13): 4.
|
[13] |
陈亚红. 慢性阻塞性肺疾病急性加重的风险识别与早期干预[J]. 中华全科医师杂志, 2019, 18(3): 296-298.
CHEN Y H. Risk identification and early intervention for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practitioners, 2019, 18(3): 296-298.
|
[14] |
胡奕卿, 方继伟, 刘焕兵, 等. 肺功能检查技术如何在基层医疗卫生服务中更好地应用: 附重点问题专家解答[J]. 中国全科医学, 2023, 26(5): 532-536.
HU Y Q, FANG J W, LIU H B, et al. How to better apply lung function testing technology in grassroots medical and health services-Expert answers to key questions[J]. Chinese General Practice, 2023, 26(5): 532-536.
|
[15] |
彭博, 张小娟, 姜骁桐, 等. 基层医疗卫生机构慢性阻塞性肺疾病基本药物与诊断设备可获得性调查研究[J]. 中国全科医学, 2022, 25(7): 771-781.
PENG B, ZHANG X J, JIANG X T, et al. A survey on the availability of essential drugs and diagnostic equipment for chronic obstructive pulmonary disease in primary healthcare institutions[J]. Chinese General Practice, 2022, 25(7): 771-781.
|
[16] |
杨群娣, 苏秋云, 陈晓英, 等. 上海市社区卫生服务中心慢性阻塞性肺疾病防控能力分析[J]. 中华全科医学, 2023, 21(3): 442-444, 525. doi: 10.16766/j.cnki.issn.1674-4152.002903
YANG Q D, SU Q Y, CHEN X Y, et al. Analysis of the Prevention and Control Capability of Chronic Obstructive Pulmonary Disease in Shanghai Community Health Service Center[J]. Chinese Journal of General Practice, 2023, 21(3): 442-444, 525. doi: 10.16766/j.cnki.issn.1674-4152.002903
|
[17] |
李凡, 盛春风, 王欢英. 提高全科医生在慢性病早期诊断和管理中的地位和作用: 以慢性阻塞性肺疾病为例[J]. 中国全科医学, 2021, 24(9): 1044-1050.
LI F, SHENG C F, WANG H Y. Enhancing the Position and Role of General Practitioners in Early Diagnosis and Management of Chronic Diseases: A Case Study of Chronic Obstructive Pulmonary Disease[J]. Chinese General Practice, 2021, 24(9): 1044-1050.
|
[18] |
逄慧, 潘子涵, 迟春花. 我国基层医疗卫生机构慢性阻塞性肺疾病呼吸康复的实施现状及展望[J]. 中华结核和呼吸杂志, 2021, 44(9): 828-833.
PANG H, PAN Z H, CHI C H. Implementation status and prospects of respiratory rehabilitation for chronic obstructive pulmonary disease in primary healthcare institutions in China[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(9): 828-833.
|
[19] |
翟文爽, 蔡汉炯, 钱佳, 等. 慢性阻塞性肺疾病患者家庭模式肺康复依从性变异曲线研究[J]. 中华全科医学, 2023, 21(7): 1157-1160, 1183. doi: 10.16766/j.cnki.issn.1674-4152.003073
ZHAI W S, CAI H J, QIAN J, et al. A study on the variation curve of family model pulmonary rehabilitation compliance in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2023, 21(7): 1157-1160, 1183. doi: 10.16766/j.cnki.issn.1674-4152.003073
|
[20] |
高连军, 赵红梅. 2017年全国各级医疗机构医生对肺康复的认知及实施状况的调查[J]. 中华结核和呼吸杂志, 2019, 42(4): 275-278.
GAO L J, ZHAO H M. A survey on the understanding and implementation of lung rehabilitation among doctors at all levels of medical institutions nationwide in 2017[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2019, 42(4): 275-278.
|
[21] |
郝兴亮, 丁菊英, 王莹莹, 等. 理论与实践结合培训对基层医师慢性阻塞性肺疾病认知的影响[J]. 中华全科医师杂志, 2022, 21(5): 477-481.
HAO X L, DING J Y, WANG Y Y, et al. The impact of theoretical and practical training on the cognition of chronic obstructive pulmonary disease among grassroots physicians[J]. Chinese Journal of General Practitioners, 2022, 21(5): 477-481.
|
[22] |
陈明敏, 叶康丽, 徐志杰, 等. 我国慢性阻塞性肺疾病社区管理现状与展望[J]. 中国全科医学, 2020, 23(3): 251-256.
CHEN M M, YE K L, XU Z J, et al. Current Status and Prospects of Community Management of Chronic Obstructive Pulmonary Disease in China[J]. Chinese General Practice, 2020, 23(3): 251-256.
|
[23] |
陈婧瑜, 林修全, 章叶发, 等. 福建省40岁及以上居民慢性阻塞性肺疾病认知现状分析[J]. 慢性病学杂志, 2019, 20(3): 347-350.
CHEN J Y, LIN X Q, ZHANG Y F, et al. Analysis of cognitive status of chronic obstructive pulmonary disease among residents aged 40 and above in Fujian Province[J]. Journal of Chronic Diseases, 2019, 20(3): 347-350.
|
[24] |
CELLI B R, SINGH D, VOGELMEIER C, et al. New perspectives on chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 2127-2136.
|
[25] |
裴士杰, 阎刚, 邵强. 错失早期诊断时间与慢性阻塞性肺疾病严重程度的关系[J]. 国际呼吸杂志, 2023, 43(2): 229-234.
PEI S J, YAN G, SHAO Q. The relationship between missed early diagnosis time and the severity of chronic obstructive pulmonary disease[J]. International Journal of Respiration, 2023, 43(2): 229-234.
|
[26] |
YAWN B P, MARTINEZ F J. Point: can screening for COPD improve outcomes? Yes[J]. Chest, 2020, 157(1): 7-9. http://www.sciencedirect.com/science/article/pii/S0012369219312516
|
[27] |
吴建忠, 黄可, 雷洁萍, 等. "中国县域慢阻肺管理中心"项目慢性阻塞性肺疾病高危人群筛查及危险因素分析[J]. 国际呼吸杂志, 2022, 42(12): 917-921.
WU J Z, HUANG K, LEI J P, et al. Screening and risk factor analysis of high-risk population for chronic obstructive pulmonary disease in the "China County Chronic Obstructive Pulmonary Disease Management Center" project[J]. International Journal of Respiration, 2022, 42(12): 917-921.
|
[28] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205.
Chronic Obstructive Pulmonary Disease Group of the Respiratory Branch of the Chinese Medical Association, Chronic Obstructive Pulmonary Disease Working Committee of the Respiratory Branch of the Chinese Medical Association. Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(3): 170-205.
|
[29] |
王凤燕, 张冬莹, 梁振宇, 等. 面向全科医生的《慢性阻塞性肺疾病诊治指南(2021年修订版)》解读[J]. 中国全科医学, 2021, 24(29): 3660-3663, 3677.
WANG F Y, ZHANG D Y, LIANG Z Y, et al. Interpretation of the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (2021 Revised Edition) for General Practitioners[J]. Chinese General Practice, 2021, 24(29): 3660-3663, 3677.
|
[30] |
王熙龙, 梁振宇, 张海云, 等. 慢性阻塞性肺疾病防控新视角: 慢阻肺前期人群的多维度思考[J]. 国际呼吸杂志, 2023, 43(2): 150-154.
WANG X L, LIANG Z Y, ZHANG H Y, et al. A New Perspective on the Prevention and Control of Chronic Obstructive Pulmonary Disease: Multidimensional Thinking of the Pre COPD Population[J]. International Journal of Respiration, 2023, 43(2): 150-154.
|
[31] |
梁振宇, 王凤燕, 陈子正, 等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2023, 26(11): 1287-1298.
LIANG Z Y, WANG F Y, CHEN Z Z, et al. Interpretation of the Key Points of the Global Strategy Update for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease by GOLD in 2023[J]. Chinese General Practice, 2023, 26(11): 1287-1298.
|
[32] |
潘明鸣, 李燕明. 提高慢性阻塞性肺疾病患者疫苗接种率: 从临床医师做起[J]. 中华结核和呼吸杂志, 2022, 45(4): 335-338.
PAN M M, LI Y M. Improving the vaccination rate of patients with chronic obstructive pulmonary disease: Starting from clinical physicians[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2022, 45(4): 335-338.
|
[33] |
吕梦轩, 祁祯楠, 迟春花. 基于可穿戴设备的智慧医疗对慢性阻塞性肺疾病管理的影响[J]. 中华全科医师杂志, 2022, 21(3): 213-218.
LYU M X, QI Z N, CHI C H. The impact of smart healthcare based on wearable devices on the management of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practitioners, 2022, 21(3): 213-218.
|